Alec Machiels's most recent trade in Apellis Pharmaceuticals Inc was a trade of 11,199 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 1, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 11,199 | 11,199 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 6,267 | 377,028 (0%) | 0% | 0 | Common Stock | |
Apellis Pharmaceuticals Inc | Machiels Alec | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 5,748 | 5,748 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 3,341 | 370,761 (0%) | 0% | 0 | Common Stock | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jul 2023 | 49,779 | 5,000 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 21 Jul 2023 | 49,779 | 367,420 (0%) | 0% | 2.7 | 132,910 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2023 | 50,000 | 54,779 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 20 Jul 2023 | 50,000 | 317,641 (0%) | 0% | 2.7 | 133,500 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Sale of securities on an exchange or to another person at price $ 64.79 per share. | 17 Jul 2023 | 1,250 | 267,641 (0%) | 0% | 64.8 | 80,988 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2023 | 1,250 | 104,779 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 17 Jul 2023 | 1,250 | 268,891 (0%) | 0% | 2.7 | 3,338 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2023 | 1,250 | 106,029 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Sale of securities on an exchange or to another person at price $ 88.41 per share. | 20 Jun 2023 | 1,250 | 267,641 (0%) | 0% | 88.4 | 110,513 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 20 Jun 2023 | 1,250 | 268,891 (0%) | 0% | 2.7 | 3,338 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 17 May 2023 | 1,250 | 268,891 (0%) | 0% | 2.7 | 3,338 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Sale of securities on an exchange or to another person at price $ 88.66 per share. | 17 May 2023 | 1,250 | 267,641 (0%) | 0% | 88.7 | 110,825 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 1,250 | 107,279 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 1,250 | 108,529 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Sale of securities on an exchange or to another person at price $ 81.05 per share. | 17 Apr 2023 | 1,250 | 267,641 (0%) | 0% | 81.1 | 101,313 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 17 Apr 2023 | 1,250 | 268,891 (0%) | 0% | 2.7 | 3,338 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 17 Mar 2023 | 1,250 | 268,891 (0%) | 0% | 2.7 | 3,338 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Mar 2023 | 1,250 | 109,779 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Sale of securities on an exchange or to another person at price $ 64.03 per share. | 17 Mar 2023 | 1,250 | 267,641 (0%) | 0% | 64.0 | 80,038 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Sale of securities on an exchange or to another person at price $ 52.38 per share. | 17 Feb 2023 | 1,250 | 267,641 (0%) | 0% | 52.4 | 65,475 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 17 Feb 2023 | 1,250 | 268,891 (0%) | 0% | 2.7 | 3,338 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 1,250 | 111,029 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 1,250 | 112,279 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Sale of securities on an exchange or to another person at price $ 52.42 per share. | 17 Jan 2023 | 1,250 | 267,641 (0%) | 0% | 52.4 | 65,525 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 17 Jan 2023 | 1,250 | 268,891 (0%) | 0% | 2.7 | 3,338 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 7,441 | 7,441 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 3,867 | 267,641 (0%) | 0% | 0 | Common Stock | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Sale of securities on an exchange or to another person at price $ 52.35 per share. | 15 Dec 2022 | 1,250 | 263,774 (0%) | 0% | 52.4 | 65,438 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2022 | 1,250 | 113,529 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 15 Dec 2022 | 1,250 | 265,024 (0%) | 0% | 2.7 | 3,338 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 15 Nov 2022 | 1,250 | 265,024 (0%) | 0% | 2.7 | 3,338 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2022 | 1,250 | 114,779 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Sale of securities on an exchange or to another person at price $ 48.01 per share. | 15 Nov 2022 | 1,250 | 263,774 (0%) | 0% | 48.0 | 60,013 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 14 Oct 2022 | 1,250 | 265,024 (0%) | 0% | 2.7 | 3,338 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Sale of securities on an exchange or to another person at price $ 59.31 per share. | 14 Oct 2022 | 1,250 | 263,774 (0%) | 0% | 59.3 | 74,138 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Oct 2022 | 1,250 | 116,029 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Sale of securities on an exchange or to another person at price $ 66.00 per share. | 15 Sep 2022 | 1,250 | 263,774 (0%) | 0% | 66 | 82,500 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2022 | 1,250 | 117,279 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 15 Sep 2022 | 1,250 | 265,024 (0%) | 0% | 2.7 | 3,338 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 15 Aug 2022 | 1,250 | 265,024 (0%) | 0% | 2.7 | 3,338 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Sale of securities on an exchange or to another person at price $ 67.21 per share. | 15 Aug 2022 | 1,250 | 263,774 (0%) | 0% | 67.2 | 84,013 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2022 | 1,250 | 118,529 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Sale of securities on an exchange or to another person at price $ 46.33 per share. | 15 Jul 2022 | 1,250 | 263,774 (0%) | 0% | 46.3 | 57,913 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 1,250 | 119,779 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 15 Jul 2022 | 1,250 | 265,024 (0%) | 0% | 2.7 | 3,338 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2022 | 1,250 | 121,029 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 15 Jun 2022 | 1,250 | 265,024 (0%) | 0% | 2.7 | 3,338 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Sale of securities on an exchange or to another person at price $ 39.29 per share. | 15 Jun 2022 | 1,250 | 263,774 (0%) | 0% | 39.3 | 49,113 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 16 May 2022 | 1,250 | 265,024 (0%) | 0% | 2.7 | 3,338 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2022 | 1,250 | 122,279 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Sale of securities on an exchange or to another person at price $ 39.18 per share. | 16 May 2022 | 1,250 | 263,774 (0%) | 0% | 39.2 | 48,975 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2022 | 1,250 | 123,529 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 14 Apr 2022 | 1,250 | 265,024 (0%) | 0% | 2.7 | 3,338 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Sale of securities on an exchange or to another person at price $ 50.90 per share. | 14 Apr 2022 | 1,250 | 263,774 (0%) | 0% | 50.9 | 63,625 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Sale of securities on an exchange or to another person at price $ 39.57 per share. | 15 Mar 2022 | 1,250 | 259,544 (0%) | 0% | 39.6 | 49,463 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 15 Mar 2022 | 1,250 | 260,794 (0%) | 0% | 2.7 | 3,338 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2022 | 1,250 | 124,779 | - | - | Stock option (right to buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 1,250 | 126,029 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Sale of securities on an exchange or to another person at price $ 45.43 per share. | 15 Feb 2022 | 1,250 | 673,774 (0%) | 0% | 45.4 | 56,788 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 15 Feb 2022 | 1,250 | 675,024 (0%) | 0% | 2.7 | 3,338 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 14 Jan 2022 | 1,250 | 675,024 (0%) | 0% | 2.7 | 3,338 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Sale of securities on an exchange or to another person at price $ 40.56 per share. | 14 Jan 2022 | 1,250 | 673,774 (0%) | 0% | 40.6 | 50,700 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2022 | 1,250 | 27,279 | - | - | Stock Option(Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 8,554 | 8,554 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 4,230 | 673,774 (0%) | 0% | 0 | Common Stock | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Sale of securities on an exchange or to another person at price $ 42.88 per share. | 15 Dec 2021 | 3,000 | 669,544 (0%) | 0% | 42.9 | 128,640 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 15 Dec 2021 | 3,000 | 672,544 (0%) | 0% | 2.7 | 8,010 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2021 | 3,000 | 128,529 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2021 | 3,000 | 131,529 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2021 | 3,000 | 134,529 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Sale of securities on an exchange or to another person at price $ 43.50 per share. | 04 Nov 2021 | 3,000 | 669,544 (0%) | 0% | 43.5 | 130,500 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 04 Nov 2021 | 3,000 | 672,544 (0%) | 0% | 2.7 | 8,010 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 04 Nov 2021 | 3,000 | 669,544 (0%) | 0% | 35 | 105,000 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 04 Nov 2021 | 3,000 | 672,544 (0%) | 0% | 2.7 | 8,010 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 16 Aug 2021 | 2,500 | 672,044 (0%) | 0% | 2.7 | 6,675 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2021 | 2,500 | 137,529 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Sale of securities on an exchange or to another person at price $ 56.95 per share. | 16 Aug 2021 | 2,500 | 669,544 (0%) | 0% | 57.0 | 142,375 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 15 Jul 2021 | 2,500 | 672,044 (0%) | 0% | 2.7 | 6,675 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Sale of securities on an exchange or to another person at price $ 62.30 per share. | 15 Jul 2021 | 2,500 | 669,544 (0%) | 0% | 62.3 | 155,750 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 2,500 | 140,029 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Sale of securities on an exchange or to another person at price $ 45.39 per share. | 14 May 2021 | 2,500 | 669,544 (0%) | 0% | 45.4 | 113,475 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 14 May 2021 | 2,500 | 672,044 (0%) | 0% | 2.7 | 6,675 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2021 | 2,500 | 145,029 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 21 Apr 2021 | 2,500 | 672,044 (0%) | 0% | 2.7 | 6,675 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2021 | 2,500 | 147,529 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Sale of securities on an exchange or to another person at price $ 45.76 per share. | 21 Apr 2021 | 2,500 | 669,544 (0%) | 0% | 45.8 | 114,400 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Sale of securities on an exchange or to another person at price $ 46.77 per share. | 15 Mar 2021 | 2,500 | 669,544 (0%) | 0% | 46.8 | 116,925 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 15 Mar 2021 | 2,500 | 672,044 (0%) | 0% | 2.7 | 6,675 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 2,500 | 150,029 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 16 Feb 2021 | 2,500 | 672,044 (0%) | 0% | 2.7 | 6,675 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 2,500 | 152,529 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Sale of securities on an exchange or to another person at price $ 46.00 per share. | 16 Feb 2021 | 2,500 | 669,544 (0%) | 0% | 46 | 115,000 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2021 | 2,500 | 155,029 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Sale of securities on an exchange or to another person at price $ 53.15 per share. | 15 Jan 2021 | 2,500 | 669,544 (0%) | 0% | 53.2 | 132,875 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 15 Jan 2021 | 2,500 | 672,044 (0%) | 0% | 2.7 | 6,675 | Common Stock |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2021 | 27,600 | 27,600 | - | - | Stock Option (Right to Buy) | |
Apellis Pharmaceuticals Inc | Alec Machiels | Director | Sale of securities on an exchange or to another person at price $ 52.16 per share. | 15 Dec 2020 | 2,500 | 669,544 (0%) | 0% | 52.2 | 130,400 | Common Stock |